Tag Archives: Bisphosphonates

Latest Medical Consensus on Preventing Breast Cancer

Posted on May 16, 2011 by wngai

Breast cancer is the most common cancer in women worldwide, with the annual incidence estimated to be 1.4 million cases in 2008.  Rates are highest in North American, Western Europe andAustralia, but the rates are also increasing in developing countries.  … Continue reading →

Posted in Breast cancer, Cancer | Tagged , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Latest Medical Consensus on Preventing Breast Cancer

Bisphosphonates May Lower the Risk for Colorectal Cancer

Posted on April 3, 2011 by wngai

A new study suggested taking bisphosphonates for osteoporosis for more than a year may reduce the risk for colorectal cancer by 60%.   The results came from an analysis of postmenopausal women who took bisphosphonates, such as alendronate (Fosamax), for more … Continue reading →

Posted in Breast cancer, Cancer, Colorectal cancer | Tagged , , , , , , , , | Comments Off on Bisphosphonates May Lower the Risk for Colorectal Cancer

Cancer Protective Benefits of Bisphosphonates

Posted on March 7, 2010 by wngai

Patients who are taking bisphosphonates products (Fosamax, Actonel and Boniva) might have a lower risk of getting breast cancer. A study published in the February issue of the British Journal of Cancer looked at the consumption of bisphosphonate products in … Continue reading →

Posted in Breast cancer, Cancer | Tagged , | Comments Off on Cancer Protective Benefits of Bisphosphonates